2026 NPPES data Ophthalmology Physician NPI 1245231059 M.D.
Verify on CMS →

MATTHEW WEINSTEIN-ZANGER, M.D.

Ophthalmology Physician in GLOUCESTER, Massachusetts. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
2K
Medicare Part D claims · 352 beneficiaries · Ophthalmology Physician avg: 1K
Generic prescribing
68%
generic claims · 32% brand-name · higher generic rates reduce patient out-of-pocket costs
MIPS score
91.4157/100
▲ 8 pts above national avg 83.1 · [object Object]

What the federal data shows

MATTHEW WEINSTEIN-ZANGER, M.D. reported a CMS MIPS final score of 91.4157/100 — above the 83.1 national average — and filed 1,657 Medicare Part D claims in 2023.

91.4157/100
MIPS score · +8 vs avg
2K
Part D claims, 2023
68%
generic prescribing
Likely
board-certified (heuristic)

Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) — no proprietary rating or editorial opinion is applied.

MATTHEW WEINSTEIN-ZANGER, M.D.'s MIPS score vs every scored U.S. clinician

CMS Merit-based Incentive Payment System (MIPS) final score, 2023 — the federal quality measure

91 Top 37% higher than 63% of 477,587 scored providers

0–10: 8,684 scored providers (2%). Below this entry. 10–20: 3,008 scored providers (1%). Below this entry. 20–30: 3,069 scored providers (1%). Below this entry. 30–40: 2,746 scored providers (1%). Below this entry. 40–50: 2,928 scored providers (1%). Below this entry. 50–60: 5,882 scored providers (1%). Below this entry. 60–70: 13,906 scored providers (3%). Below this entry. 70–80: 118,074 scored providers (25%). Below this entry. 80–90: 129,887 scored providers (27%). Below this entry. 90–100: 189,403 scored providers (40%). This entry sits in this band. This provider 0 100 every MIPS-scored clinician, bucketed by value

Each bar is a band; taller bars hold more scored providers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source CMS Merit-based Incentive Payment System (MIPS) · 2023

Board certification likely (heuristic — not verified)

MATTHEW WEINSTEIN-ZANGER, M.D. practices in an ABMS-board-eligible specialty and shows active CMS Medicare participation + MIPS quality reporting + 2 hospital affiliations — signals consistent with board-certified status. For verified board certification, see CertificationMatters.org (the official ABMS public lookup).

What does the federal data show about MATTHEW WEINSTEIN-ZANGER, M.D.?

High performer (top quartile)

NPI registry status

Active

Issued 08/02/2005

NPI 1245231059

Primary specialty

Ophthalmology Physician

Mid-sized

22,090 US NPIs in this specialty

Medicare Part D claims

1,657 17% vs specialty avg

2023 prescription claims

Specialty avg: 1,420

MIPS final score

91.4157/100 8.315700000000007% pts

Exceptional band

vs 83.1 national avg

Specialty distribution in Massachusetts

How Ophthalmology Physician compares to other specialties among Massachusetts providers

Massachusetts providers

Ophthalmology Physician share within Massachusetts

1. Ophthalmology Physician42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Ophthalmology Physician share within Massachusetts

Medicare quality performance — MIPS

MATTHEW WEINSTEIN-ZANGER, M.D.'s 2023 MIPS final score plotted against the Ophthalmology Physician national average

High performer (top quartile)
MIPS Final Score
91.4157/100
vs 83.1 national avg · 2023 performance year

MIPS final score (Ophthalmology Physician) — 91.4157/100 vs national avg 83.1

0%100%National avg83%91.4%
MIPS final score (Ophthalmology Physician) — 91.4157/100 vs national avg 83.1

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MATTHEW WEINSTEIN-ZANGER, M.D. appears in the CMS NPPES registry as a Ophthalmology Physician provider holding M.D. credentials at 35 MIDDLE ST, GLOUCESTER, MA, 01930, with a listed phone of (978) 281-0600. NPI 1245231059 was issued on 08/02/2005. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what WEINSTEIN-ZANGER most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,657 prescription claims written by this provider, covering 352 Medicare beneficiaries and totaling roughly $106K in drug spend, split 32% brand-name and 68% generic by claim count. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy. On the CMS Merit-based Incentive Payment System, this provider earned a Final Score of 91.4157/100 for the 2023 performance year (Quality 76.877), compared with the national average of 83.1.

Ophthalmology Physician is a mid-sized specialty nationwide, with 22,090 enrolled providers across 56 states and an average of 1,420 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

35 MIDDLE ST
GLOUCESTER, MA 01930

Provider Details

NPI 1245231059
Specialty Ophthalmology Physician
Credentials M.D.
Gender Male
NPI Issued 08/02/2005

CMS Quality Score (MIPS)

Merit-based Incentive Payment System (MIPS) scores from CMS, 2023 performance year.

91.4157
Final Score
Avg: 83.1
76.877
Quality
100
Promoting Interoperability

Reporting: Alternative Payment Model

Hospital and facility affiliations

Facilities where MATTHEW WEINSTEIN-ZANGER, M.D. bills Medicare from. Star ratings (1-5) are CMS Hospital Compare's "Hospital overall rating" — a composite of mortality, readmission, patient experience, safety, timely care, and efficient use of medical imaging measures. Source: CMS Care Compare.

CAPE ANN EYE SPECIALISTS, P.C.
GLOUCESTER, MA
PRATT OPHTHALMOLOGY ASSOCIATES INC
BOSTON, MA

Affiliations sourced from CMS Doctors and Clinicians National Downloadable File; hospital ratings from CMS Hospital General Information dataset (cross-referenced by facility name + state).

License & disciplinary context — Massachusetts BORIM 2023 annual report

Aggregate state board data only — NOT a determination of any individual provider's status. The figures below describe statewide disciplinary activity across all ~38K Massachusetts medical licensees in 2023 — they are NOT specific to MATTHEW WEINSTEIN-ZANGER, M.D.. To verify MATTHEW WEINSTEIN-ZANGER, M.D.'s current license status, search the BORIM public license lookup directly, or check the Federation of State Medical Boards (FSMB) verification service.

80
Total board actions, Massachusetts 2023
Across 78 cases
2.11
Actions per 1,000 licensees
Massachusetts statewide rate
probation
Most common action type
29 cases

BORIM publishes annual disciplinary statistics as part of public-record reporting under each state's Administrative Procedure Act. See the full breakdown by action type and year on the Massachusetts disciplinary trends page. Cross-checked against FSMB U.S. Medical Regulatory Trends.

Brand vs generic prescribing mix · Above average

MATTHEW WEINSTEIN-ZANGER, M.D. — brand share 32.0%
Specialty average (est.)

32% brand-name claims vs 68% generic, on 1,657 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,657
Total Claims
$106K
Total Drug Cost
352
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,474
Total Day Supply
66,242
Brand vs Generic
32% brand / 68% generic
Brand Drug Cost
$83K
Generic Drug Cost
$23K

Patient Demographics

Average Patient Age
77.0 years
Avg HCC Risk Score
1.01
Gender Split
61% female / 39% male

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

What MATTHEW WEINSTEIN-ZANGER, M.D. prescribes most

Top Medicare Part D drugs by claim count, 2023

claims
Source CMS Medicare Part D Prescriber Public Use File As of 2023
Drug Claims
Latanoprost
442
Prednisolone Acetate
320
Ketorolac Tromethamine
290
Ofloxacin
284
Timolol Maleate
79
Restasis
Cyclosporine
46
Dorzolamide-Timolol
Dorzolamide Hcl/Timolol Maleat
29
Dorzolamide Hcl
25
Brimonidine Tartrate-Timolol
Brimonidine Tartrate/Timolol
24
Combigan
Brimonidine Tartrate/Timolol
19

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Ophthalmology Physician Overview

How MATTHEW WEINSTEIN-ZANGER, M.D. fits within the Ophthalmology Physician landscape nationally.

22,090
Ophthalmology Physician Providers in US
56
States with Ophthalmology Physician
1,420
Avg Claims per Provider

MATTHEW WEINSTEIN-ZANGER, M.D.'s 1,657 claims are above the specialty average of 1,420.

Nearby Ophthalmology Physician Providers in Massachusetts

Other clinicians with the same primary specialty enrolled in Massachusetts, drawn from the same CMS NPPES roster as WEINSTEIN-ZANGER.

Compare Ophthalmology Physician nationally: see state-by-state distribution →

Frequently Asked Questions

What is MATTHEW WEINSTEIN-ZANGER, M.D.'s specialty?
MATTHEW WEINSTEIN-ZANGER, M.D. specializes in Ophthalmology Physician and practices in GLOUCESTER, Massachusetts. Credentials: M.D..
How much does MATTHEW WEINSTEIN-ZANGER, M.D. prescribe under Medicare Part D?
In 2023, MATTHEW WEINSTEIN-ZANGER, M.D. wrote 1,657 Medicare Part D claims totaling $106K in drug costs for 352 beneficiaries.
What is MATTHEW WEINSTEIN-ZANGER, M.D.'s Medicare quality score?
MATTHEW WEINSTEIN-ZANGER, M.D. has a CMS MIPS Final Score of 91.4157/100 (Quality: 76.877). The national average MIPS Final Score is 83.1. Source: CMS Merit-based Incentive Payment System (MIPS) 2023.
Where is MATTHEW WEINSTEIN-ZANGER, M.D. located?
MATTHEW WEINSTEIN-ZANGER, M.D. is located at 35 MIDDLE ST, GLOUCESTER, MA, 01930. Phone: (978) 281-0600.
What is MATTHEW WEINSTEIN-ZANGER, M.D.'s NPI number?
MATTHEW WEINSTEIN-ZANGER, M.D.'s National Provider Identifier (NPI) is 1245231059, issued on 08/02/2005.
Does MATTHEW WEINSTEIN-ZANGER, M.D. prescribe more brand-name or generic drugs?
MATTHEW WEINSTEIN-ZANGER, M.D.'s prescribing is 32% brand-name and 68% generic drugs by claim count, with $83K in brand drug costs.
How many Ophthalmology Physician providers are there in the US?
There are 22,090 Ophthalmology Physician providers across 56 states in the US. The average Ophthalmology Physician provider writes 1,420 Medicare Part D claims per year.
What drugs does MATTHEW WEINSTEIN-ZANGER, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MATTHEW WEINSTEIN-ZANGER, M.D.'s most frequently prescribed drugs include Latanoprost, Prednisolone Acetate, Ketorolac Tromethamine. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MATTHEW WEINSTEIN-ZANGER, M.D. accept Medicare?
MATTHEW WEINSTEIN-ZANGER, M.D. appears in CMS Medicare data with 1,657 Part D claims and 352 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MATTHEW WEINSTEIN-ZANGER, M.D.'s credentials?
MATTHEW WEINSTEIN-ZANGER, M.D.'s NPI is 1245231059 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Quality Performance
CMS Merit-based Incentive Payment System (MIPS) — 2023 performance year.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology